ArticleRevista de neurologia2022

Outcome of SARS-CoV-2 associated Guillain-Barre syndrome depends on early treatment and vaccination.

J Finsterer et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.